OBJECTIVE: Recent findings suggest that ultraviolet (UV) radiation exposure may reduce risk of developing non-Hodgkin lymphoma (NHL), but the biologic basis for this relationship remains unclear. We analyzed data from our US population-based case-control study of NHL to investigate whether our previously reported inverse association with sun exposure was dependent upon variants in the vitamin D receptor gene (IVS10 + 283G > A (BsmI), Ex11 + 32T > C (TaqI)), and genes linked to UV-induced immune modulation (IL4, IL10, IL12A, IL12B, TNF). METHODS: UV exposure data was collected from an in-person interview with 551 cases and 462 controls. We calculated odds ratios (OR) and 95% confidence intervals (CI) for sun exposure measures for joint variant-exposure effects. RESULTS: The association with NHL risk for time in the midday sun within the last decade was dependent upon Ex11 + 32 T > C genotype. Compared to TT carriers who reported < 7 h/week of sun exposure, CC subjects with < 7 h/week of sun exposure had an increased risk of NHL (OR = 1.9, 95% CI 0.8-4.4, P(interaction) = 0.16), while the relative risks for other CC carriers approached unity with increasing level of sun exposure. This pattern of effects was especially apparent for follicular lymphoma (for CC genotype and < 7 h/week of exposure: OR 6.3, 95% CI 1.9-22, P(interaction) = 0.004), and was consistently observed across measures of reported sun exposure for different periods of life. As IVS10 + 283G > A is correlated with Ex11 + 32T > C in our population (r (2) = 0.95), results were equivalent for those with the IVS10 + 283 AA genotype. No evidence of interaction with cytokine gene variants was observed. CONCLUSIONS: Our results suggest that the inverse association between UV exposure and NHL risk may be mediated by the vitamin D pathway. Further investigation of this finding in other studies is warranted.
OBJECTIVE: Recent findings suggest that ultraviolet (UV) radiation exposure may reduce risk of developing non-Hodgkin lymphoma (NHL), but the biologic basis for this relationship remains unclear. We analyzed data from our US population-based case-control study of NHL to investigate whether our previously reported inverse association with sun exposure was dependent upon variants in the vitamin D receptor gene (IVS10 + 283G > A (BsmI), Ex11 + 32T > C (TaqI)), and genes linked to UV-induced immune modulation (IL4, IL10, IL12A, IL12B, TNF). METHODS: UV exposure data was collected from an in-person interview with 551 cases and 462 controls. We calculated odds ratios (OR) and 95% confidence intervals (CI) for sun exposure measures for joint variant-exposure effects. RESULTS: The association with NHL risk for time in the midday sun within the last decade was dependent upon Ex11 + 32 T > C genotype. Compared to TT carriers who reported < 7 h/week of sun exposure, CC subjects with < 7 h/week of sun exposure had an increased risk of NHL (OR = 1.9, 95% CI 0.8-4.4, P(interaction) = 0.16), while the relative risks for other CC carriers approached unity with increasing level of sun exposure. This pattern of effects was especially apparent for follicular lymphoma (for CC genotype and < 7 h/week of exposure: OR 6.3, 95% CI 1.9-22, P(interaction) = 0.004), and was consistently observed across measures of reported sun exposure for different periods of life. As IVS10 + 283G > A is correlated with Ex11 + 32T > C in our population (r (2) = 0.95), results were equivalent for those with the IVS10 + 283 AA genotype. No evidence of interaction with cytokine gene variants was observed. CONCLUSIONS: Our results suggest that the inverse association between UV exposure and NHL risk may be mediated by the vitamin D pathway. Further investigation of this finding in other studies is warranted.
Authors: Jennifer L Kelly; Jonathan W Friedberg; Laura M Calvi; Edwin van Wijngaarden; Susan G Fisher Journal: Cancer Causes Control Date: 2010-04-07 Impact factor: 2.506
Authors: Jennifer L Kelly; Jonathan W Friedberg; Laura M Calvi; Edwin van Wijngaarden; Susan G Fisher Journal: Cancer Invest Date: 2009-11 Impact factor: 2.176
Authors: Ellen T Chang; Alison J Canchola; Myles Cockburn; Yani Lu; Sophia S Wang; Leslie Bernstein; Christina A Clarke; Pamela L Horn-Ross Journal: Blood Date: 2011-05-26 Impact factor: 22.113
Authors: Jennifer L Kelly; Matthew T Drake; Zachary S Fredericksen; Yan W Asmann; Mark Liebow; Tait D Shanafelt; Andrew L Feldman; Stephen M Ansell; William R Macon; Megan M Herr; Alice H Wang; Grzegorz S Nowakowski; Timothy G Call; Thomas M Habermann; Susan L Slager; Thomas E Witzig; James R Cerhan Journal: Cancer Causes Control Date: 2012-04-28 Impact factor: 2.506
Authors: Mark P Purdue; D Michal Freedman; Susan M Gapstur; Kathy J Helzlsouer; Francine Laden; Unhee Lim; Gertraud Maskarinec; Nathaniel Rothman; Xiao-Ou Shu; Victoria L Stevens; Anne Zeleniuch-Jacquotte; Demetrius Albanes; Kimberly Bertrand; Stephanie J Weinstein; Kai Yu; Lonn Irish; Ronald L Horst; Judith Hoffman-Bolton; Edward L Giovannucci; Laurence N Kolonel; Kirk Snyder; Walter Willett; Alan A Arslan; Richard B Hayes; Wei Zheng; Yong-Bing Xiang; Patricia Hartge Journal: Am J Epidemiol Date: 2010-06-18 Impact factor: 4.897
Authors: Unhee Lim; D Michal Freedman; Bruce W Hollis; Ronald L Horst; Mark P Purdue; Nilanjan Chatterjee; Stephanie J Weinstein; Lindsay M Morton; Arthur Schatzkin; Jarmo Virtamo; Martha S Linet; Patricia Hartge; Demetrius Albanes Journal: Int J Cancer Date: 2009-02-15 Impact factor: 7.396
Authors: S Karami; P Brennan; M Navratilova; D Mates; D Zaridze; V Janout; H Kollarova; V Bencko; V Matveev; N Szesznia-Dabrowska; I Holcatova; M Yeager; S Chanock; N Rothman; P Boffetta; W-H Chow; L E Moore Journal: Int J Endocrinol Date: 2009-11-05 Impact factor: 3.257